COMP <GO>
NVST vs ATRC // REVENUE GROWTH (YOY)
Envista Holdings Corporation (NYSE) VS. AtriCure Inc. (NASDAQ) • 15-METRIC TALLY: NVST 6
— ATRC 4
▲ REVENUE GROWTH (YOY) LEADER: ATRC
LAST: $24.61 (+2.80%) • MKT CAP: $3.95B
revenue-growth
8.30%
LAST: $62.48 (+1.73%) • MKT CAP: $3.18B
revenue-growth
14.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVST VS. ATRC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVST | ATRC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.70% | 75.00% | -20.30 | ATRC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.10% | -1.90% | +7.00 | NVST | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.83% | 1.52% | +4.31 | NVST | /fcf-yield <GO> |
| Operating Margin | 7.90% | -1.80% | +9.70 | NVST | /operating-margins <GO> |
| Net Profit Margin | 1.70% | -2.10% | +3.80 | NVST | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 8.30% | 14.90% | -6.60 | ATRC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.61 | 12.08 | -10.47 | ATRC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | NVST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 66.0 | -9.20 | ATRC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 78.2x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.95B | $3.18B | $774.7M | NVST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVST REV | ATRC REV | NVST GROSS % | ATRC GROSS % | NVST FCF | ATRC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.72B | $534.5M | 54.7% | 75.0% | $230.4M | $48.3M |
| FY 2024 | $2.51B | $465.3M | 54.7% | 74.7% | $302.7M | $745.0K |
| FY 2023 | $2.57B | $399.2M | — | — | $160.2M | $4.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVST // BETA 0.93
ATRC // BETA —